skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:057059/0802   Pages: 9
Recorded: 08/02/2021
Attorney Dkt #:104066-0970171
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 30
1
Patent #:
10138462
Issue Dt:
11/27/2018
Application #:
10008955
Filing Dt:
12/07/2001
Publication #:
US20020068044
Pub Dt:
06/06/2002
Title:
Natural killer cell lines and methods of use
2
Patent #:
8034332
Issue Dt:
10/11/2011
Application #:
10456237
Filing Dt:
06/06/2003
Publication #:
US20040052770
Pub Dt:
03/18/2004
Title:
INTERLEUKIN-SECRETING NATURAL KILLER CELL LINES AND METHODS OF USE
3
Patent #:
10258649
Issue Dt:
04/16/2019
Application #:
15032518
Filing Dt:
04/27/2016
Publication #:
US20160250256
Pub Dt:
09/01/2016
Title:
TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
4
Patent #:
10456420
Issue Dt:
10/29/2019
Application #:
15529848
Filing Dt:
05/25/2017
Publication #:
US20180193383
Pub Dt:
07/12/2018
Title:
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
5
Patent #:
10801013
Issue Dt:
10/13/2020
Application #:
15914665
Filing Dt:
03/07/2018
Publication #:
US20180258397
Pub Dt:
09/13/2018
Title:
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
6
Patent #:
10646516
Issue Dt:
05/12/2020
Application #:
16212578
Filing Dt:
12/06/2018
Publication #:
US20190125801
Pub Dt:
05/02/2019
Title:
TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
7
Patent #:
10517895
Issue Dt:
12/31/2019
Application #:
16289494
Filing Dt:
02/28/2019
Publication #:
US20190192568
Pub Dt:
06/27/2019
Title:
TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
8
Patent #:
10772912
Issue Dt:
09/15/2020
Application #:
16289512
Filing Dt:
02/28/2019
Publication #:
US20190192569
Pub Dt:
06/27/2019
Title:
A TUMORICIDAL AND ANTIMICROBIAL COMPOSITION
9
Patent #:
11213547
Issue Dt:
01/04/2022
Application #:
16289526
Filing Dt:
02/28/2019
Publication #:
US20190192570
Pub Dt:
06/27/2019
Title:
TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
10
Patent #:
NONE
Issue Dt:
Application #:
16337996
Filing Dt:
03/29/2019
Publication #:
US20190233797
Pub Dt:
08/01/2019
Title:
HLA CLASS I-DEFICIENT NK-92 CELLS WITH DECREASED IMMUNOGENICITY
11
Patent #:
10774310
Issue Dt:
09/15/2020
Application #:
16424201
Filing Dt:
05/28/2019
Publication #:
US20190300854
Pub Dt:
10/03/2019
Title:
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
12
Patent #:
NONE
Issue Dt:
Application #:
16475926
Filing Dt:
07/03/2019
Publication #:
US20200123503
Pub Dt:
04/23/2020
Title:
GENETICALLY MODIFIED NK-92 CELLS WITH DECREASED CD96/TIGIT EXPRESSION
13
Patent #:
10736921
Issue Dt:
08/11/2020
Application #:
16541847
Filing Dt:
08/15/2019
Publication #:
US20190365816
Pub Dt:
12/05/2019
Title:
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER
14
Patent #:
11304977
Issue Dt:
04/19/2022
Application #:
16598418
Filing Dt:
10/10/2019
Publication #:
US20200038445
Pub Dt:
02/06/2020
Title:
TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
15
Patent #:
NONE
Issue Dt:
Application #:
16604341
Filing Dt:
10/10/2019
Publication #:
US20200155599
Pub Dt:
05/21/2020
Title:
ANTI-EGFR/HIGH AFFINITY NK-CELLS COMPOSITIONS AND METHODS FOR CHORDOMA TREATMENT
16
Patent #:
NONE
Issue Dt:
Application #:
16620791
Filing Dt:
12/09/2019
Publication #:
US20200121720
Pub Dt:
04/23/2020
Title:
NK-92 CELLS AND IL-15 AGONIST COMBINATION THERAPY
17
Patent #:
NONE
Issue Dt:
Application #:
16620855
Filing Dt:
12/09/2019
Publication #:
US20200171087
Pub Dt:
06/04/2020
Title:
METHODS FOR TREATING MERKEL CELL CARCINOMA (MCC) USING NK-92 CELLS
18
Patent #:
NONE
Issue Dt:
Application #:
16760893
Filing Dt:
04/30/2020
Publication #:
US20210187024
Pub Dt:
06/24/2021
Title:
NK-92 Cells to Stimulate Anti-Cancer Vaccine
19
Patent #:
11000550
Issue Dt:
05/11/2021
Application #:
16903882
Filing Dt:
06/17/2020
Publication #:
US20200306312
Pub Dt:
10/01/2020
Title:
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER
20
Patent #:
11753625
Issue Dt:
09/12/2023
Application #:
16937370
Filing Dt:
07/23/2020
Publication #:
US20200347351
Pub Dt:
11/05/2020
Title:
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
21
Patent #:
NONE
Issue Dt:
Application #:
16964962
Filing Dt:
07/24/2020
Publication #:
US20210040451
Pub Dt:
02/11/2021
Title:
USE OF 5% HUMAN ALBUMIN IN WASH AND HARVEST MEDIA
22
Patent #:
NONE
Issue Dt:
Application #:
17057239
Filing Dt:
11/20/2020
Publication #:
US20210163868
Pub Dt:
06/03/2021
Title:
METHODS AND SYSTEMS FOR CELL BED FORMATION DURING BIOPROCESSING
23
Patent #:
NONE
Issue Dt:
Application #:
17057494
Filing Dt:
11/20/2020
Publication #:
US20210363484
Pub Dt:
11/25/2021
Title:
OPTIMIZATION OF NK-92 CELL GROWTH USING POLOXAMER
24
Patent #:
11351196
Issue Dt:
06/07/2022
Application #:
17151085
Filing Dt:
01/15/2021
Publication #:
US20210205367
Pub Dt:
07/08/2021
Title:
GENERATING CIK NKT CELLS FROM CORD BLOOD
25
Patent #:
11207350
Issue Dt:
12/28/2021
Application #:
17217839
Filing Dt:
03/30/2021
Publication #:
US20210236550
Pub Dt:
08/05/2021
Title:
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
26
Patent #:
NONE
Issue Dt:
Application #:
17260544
Filing Dt:
01/14/2021
Publication #:
US20220133789
Pub Dt:
05/05/2022
Title:
GENERATING CIK NKT CELLS FROM CORD BLOOD
27
Patent #:
NONE
Issue Dt:
Application #:
17260545
Filing Dt:
01/14/2021
Publication #:
US20210267190
Pub Dt:
09/02/2021
Title:
CRYOPRESERVATION
28
Patent #:
NONE
Issue Dt:
Application #:
17264601
Filing Dt:
01/29/2021
Publication #:
US20210293787
Pub Dt:
09/23/2021
Title:
COMBINED INVASION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING TARGET CELLS
29
Patent #:
NONE
Issue Dt:
Application #:
17264990
Filing Dt:
02/01/2021
Publication #:
US20210324042
Pub Dt:
10/21/2021
Title:
CHEMOKINE RESPONSIVE ACTIVATED NATURAL KILLER CELLS WITH SECONDARY HOMING ACTIVATION FOR VERIFIED TARGETS
30
Patent #:
NONE
Issue Dt:
Application #:
17295010
Filing Dt:
05/18/2021
Publication #:
US20220017594
Pub Dt:
01/20/2022
Title:
IL-2 DEPENDENT NK-92 CELLS WITH STABLE FC RECEPTOR EXPRESSION
Assignor
1
NANTKWEST, INC.
Exec Dt:
03/09/2021
Assignee
1
IMMUNITYBIO, INC.
3530 JOHN HOPKINS COURT
SAN DIEGO, CALIFORNIA 92121
Correspondence name and address
KILPATRICK TOWNSEND & STOCKTON LLP
TWO EMBARCADERO CENTER, SUITE 1900
SAN FRANCISCO, CA 94111-3834

Search Results as of: 05/25/2024 10:20 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT